Tumor Microenvironment Multiple Responsive Nanoparticles for Targeted Delivery of Doxorubicin and CpG Against Triple-Negative Breast Cancer

INTRODUCTION: Currently, the main treatment for advanced breast cancer is still chemotherapy. Immunological and chemical combination therapy has a coordinated therapeutic effect and achieves some efficacy. However, the immunosuppressive tumor microenvironment is a major cause for the failure of immu...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Fenfen, Hu, Chuling, Cao, Wei, Li, Chao, Xia, Qingming, Gao, Yuan, Liu, Yan, Gao, Shen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508944/
https://www.ncbi.nlm.nih.gov/pubmed/36164553
http://dx.doi.org/10.2147/IJN.S377702

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508944/
https://www.ncbi.nlm.nih.gov/pubmed/36164553
http://dx.doi.org/10.2147/IJN.S377702

Ejemplares similares